Amphotericin B Not Yet Recruiting Phase 4 Trials for Visceral Leishmaniasis Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01566552Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis